. >> we continue by looking at theranos with john carreyrou and michael siconolfi of the the wage wawj. >> she came out of stanford with this vision of trying to revolutionize medicine with blood testing that would be done on very small samples of blood, either priked from the arm, at first prked from the arm then priked from the finger and the test would be done quickly, off just this painless pin prik, and then you would be able to diagnose a bunch of conditions from that. and that was pretty transform tiff, if it was achievable, if the company could do it, it really meant big changes in medicine and in the laboratory testing industry. so the vision was a powerful one that a lot of people bought into. but again, the people who invested early knew they were facing a young lady who had just graduated and who might fail as most entrepreneurs in silicon valley failed. >> we conclude with amy adams. she spoke to a.o. scott at the "new york times" about her two new films, arrival and nocturnal animals. >> i'm definitely hard on myself and work really hard but i'm so much more relaxed than

joining me now are john carreyrou. i am pleased to have both at this table. een 13 months of reporting in the journal, but longer than that actually, looking into theranos. john, when did you first get an indication that something might be amiss? >> there was a "new yorker" piece in december of 2014, a long profile of elizabeth holmes. that piece both put on my radar. she had gotten a fair amount of press, but i had not paid much attention until i saw that story. in addition to putting her on my radar, just in general, they are decoupled passages that i thought were strange. i had done investigative reporting in health care for the last decade. having a fair amount of experience, there were some passages that seemed off to me. i probably would not have done anything with that, but a couple of weeks later i got a tip. host: which passages? >> they were a couple of skeptical passages in the piece about the regulatory sort of no man's land, that this company was sort of charting, its path. then, there was also a paragraph in which the writer asked her how the tec